ATE344235T1 - Monohydrat des cis-lithium-cyano-4-[3- (cyclopentyloy)-4- methoxyphenylöcyclohexancarboxylats - Google Patents

Monohydrat des cis-lithium-cyano-4-[3- (cyclopentyloy)-4- methoxyphenylöcyclohexancarboxylats

Info

Publication number
ATE344235T1
ATE344235T1 AT01904886T AT01904886T ATE344235T1 AT E344235 T1 ATE344235 T1 AT E344235T1 AT 01904886 T AT01904886 T AT 01904886T AT 01904886 T AT01904886 T AT 01904886T AT E344235 T1 ATE344235 T1 AT E344235T1
Authority
AT
Austria
Prior art keywords
methoxyphenylöcyclohexanecarboxylate
cyclopentyloy
monohydrate
cis
cyano
Prior art date
Application number
AT01904886T
Other languages
English (en)
Inventor
Kevin Scott Webb
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE344235T1 publication Critical patent/ATE344235T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C255/46—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of non-condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/50—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01904886T 2000-01-26 2001-01-18 Monohydrat des cis-lithium-cyano-4-[3- (cyclopentyloy)-4- methoxyphenylöcyclohexancarboxylats ATE344235T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17812900P 2000-01-26 2000-01-26

Publications (1)

Publication Number Publication Date
ATE344235T1 true ATE344235T1 (de) 2006-11-15

Family

ID=22651319

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01904886T ATE344235T1 (de) 2000-01-26 2001-01-18 Monohydrat des cis-lithium-cyano-4-[3- (cyclopentyloy)-4- methoxyphenylöcyclohexancarboxylats

Country Status (36)

Country Link
US (1) US6699903B2 (de)
EP (1) EP1250313B1 (de)
JP (1) JP2003520842A (de)
KR (1) KR20020073183A (de)
CN (1) CN1157371C (de)
AP (1) AP1432A (de)
AR (1) AR027273A1 (de)
AT (1) ATE344235T1 (de)
AU (1) AU3282201A (de)
BG (1) BG106959A (de)
BR (1) BR0107709A (de)
CA (1) CA2397758A1 (de)
CO (1) CO5300517A1 (de)
CY (1) CY1108515T1 (de)
CZ (1) CZ20022590A3 (de)
DE (1) DE60124221T2 (de)
DK (1) DK1250313T3 (de)
DZ (1) DZ3285A1 (de)
EA (1) EA200200791A1 (de)
EG (1) EG24065A (de)
ES (1) ES2273804T3 (de)
HK (1) HK1051030A1 (de)
HU (1) HUP0204150A3 (de)
IL (1) IL150400A0 (de)
MA (1) MA25652A1 (de)
MX (1) MXPA02007300A (de)
MY (1) MY122802A (de)
NO (1) NO20023378L (de)
NZ (1) NZ519799A (de)
OA (1) OA12159A (de)
PE (1) PE20011040A1 (de)
PL (1) PL356832A1 (de)
PT (1) PT1250313E (de)
SK (1) SK10942002A3 (de)
WO (1) WO2001055094A1 (de)
ZA (1) ZA200205925B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011802D0 (en) * 2000-05-16 2000-07-05 Smithkline Beecham Method for enhancing cognitive function

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU677776B2 (en) * 1992-04-02 1997-05-08 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
UA67753C2 (uk) * 1997-10-10 2004-07-15 Смітклайн Бічам Корпорейшн Спосіб отримання заміщених 4-феніл-4-ціанциклогексанових кислот

Also Published As

Publication number Publication date
BR0107709A (pt) 2002-11-19
MY122802A (en) 2006-05-31
CO5300517A1 (es) 2003-07-31
CZ20022590A3 (cs) 2003-01-15
CN1395556A (zh) 2003-02-05
CY1108515T1 (el) 2014-04-09
IL150400A0 (en) 2002-12-01
DZ3285A1 (fr) 2001-08-02
EP1250313A4 (de) 2005-09-21
PE20011040A1 (es) 2001-10-31
OA12159A (en) 2006-05-08
AR027273A1 (es) 2003-03-19
BG106959A (en) 2003-05-30
AU3282201A (en) 2001-08-07
AP2002002566A0 (en) 2002-06-30
HUP0204150A3 (en) 2003-05-28
WO2001055094A1 (en) 2001-08-02
SK10942002A3 (sk) 2002-11-06
EP1250313B1 (de) 2006-11-02
US6699903B2 (en) 2004-03-02
NO20023378D0 (no) 2002-07-12
PL356832A1 (en) 2004-07-12
EP1250313A1 (de) 2002-10-23
MXPA02007300A (es) 2002-11-29
AP1432A (en) 2005-06-20
CN1157371C (zh) 2004-07-14
NO20023378L (no) 2002-07-12
ZA200205925B (en) 2003-11-21
DK1250313T3 (da) 2007-02-12
MA25652A1 (fr) 2002-12-31
NZ519799A (en) 2004-04-30
DE60124221D1 (de) 2006-12-14
EA200200791A1 (ru) 2002-12-26
JP2003520842A (ja) 2003-07-08
US20030032670A1 (en) 2003-02-13
HUP0204150A2 (hu) 2003-04-28
KR20020073183A (ko) 2002-09-19
PT1250313E (pt) 2007-01-31
ES2273804T3 (es) 2007-05-16
DE60124221T2 (de) 2007-09-13
CA2397758A1 (en) 2001-08-02
HK1051030A1 (zh) 2003-07-18
EG24065A (en) 2008-05-08

Similar Documents

Publication Publication Date Title
AR028567A1 (es) Nuevos derivados de fenil-propargileter
AR028253A1 (es) Inhibidores de la glucogeno fosforilasa
ATE223396T1 (de) Kristalline base des citaloprams
AR028596A1 (es) Nuevos derivados de fenilglicina
ID30590A (id) Celana sekali pakai jenis-celana pendek
DZ3409A1 (fr) Association therapeuthique
ATE258918T1 (de) Kristallform alpha des perindopril-tert- butylaminsalzes
MA27126A1 (fr) 3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES
ID30187A (id) Dongkrak jenis pantagraf
EE200200701A (et) Kõrgkontsentreeritud stabiilsed meloksikaami lahused
PT1250321E (pt) Composicao de gliburida
DE60144211D1 (de) Geteilte Peripherie-Architektur
DE60137156D1 (de) Kühlschrank
FR2809740B1 (fr) Melanges de stabilisants
ID30465A (id) Mekanisme pengarah petransmisi daya selubung
IT1324892B (it) Miscele di agenti stabilizzanti
DE60009451D1 (de) Massagegerät
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
FR2809738B1 (fr) Melanges de stabilisants
EE200200389A (et) Imidasooli uued derivaadid
ATE344235T1 (de) Monohydrat des cis-lithium-cyano-4-[3- (cyclopentyloy)-4- methoxyphenylöcyclohexancarboxylats
EE200300434A (et) Farmatseutiliselt toimivate ühendite kasutamine
UA4579S (uk) Дозиметр-радіометр гамма-бета-випромінювань
FR2810531B1 (fr) Trocart de coelio-chirurgie
FIU20000034U0 (fi) Kanteleen sävelvaihtomekanismi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1250313

Country of ref document: EP

REN Ceased due to non-payment of the annual fee